why choose us

First received: August 04, 2023

Clinical Trial: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastrointestinal Cancer

Study Type: INTERVENTIONAL


Official Title: TREK: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

Brief Summary: The goal of this open-label clinical trial is to assess the feasibility of Ketamine-assisted psychotherapy (KAP) studies for adults with non-operable GI cancers suffering with existential distress.The main questions it aims to answer are:Is it feasible to conduct a KAP study with this population?What is the safety and tolerability of KAP in this population?How prevalent is existential distress in this population?Participants will undergo KAP administered as standard of care at the HMHI Park City Ketamine-Assisted…

Read more